DGF: Clinical Trials

4 trials for DGF, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow DGF: new trials by email Literature Review of DGF trials Research Report on DGF

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Does Early Postoperative Fluid Management Affect Functional Delayed Graft Function After Living Donor Kidney Transplantation?
Renal Transplant, DGF
Active not recruitingAnkara University1222025-09-012026-02-12
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Ravulizumab, Placebo - Delayed Graft Function, DGF
Phase 3RecruitingAlexion Pharmaceuticals, Inc.4502025-05-192026-06-18
Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney Transplantation
Highly suppressive Treg measurement - DGF, Kidney Transplant; Complications
Active not recruitingSt. Louis University1802020-12-072025-12-17
A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.
Liver transplantation - Hepatocellular Carcinoma (HCC), DGF
CompletedJian You1312020-01-012024-10-04

Narrower conditions

Carcinoma, Hepatocellular (1)  ·  Delayed Graft Function (1)

Broader conditions

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Liver Transplantation (1)  ·  ravulizumab (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)  ·  Ankara University (1)  ·  Jian You (1)  ·  St. Louis University (1)

Countries

China (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Portugal (1)  ·  South Korea (1)

Top investigators

Henry Randall, MD (1)